Income Statement
P3 HEALTH PARTNERS INC.
PIII
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|
|
Revenue
|
1,500.46 | 1,266.38 | 1,049.47 | - |
|
Cost of Revenue
|
- | - | - | - |
|
Gross Profit
|
1,500.46 | 1,266.38 | 1,049.47 | - |
|
Operating Expenses
|
1,821.11 | 1,434.31 | 2,610.38 | 0.00 |
|
Research & Development
|
- | - | - | - |
|
Selling, General & Administrative
|
112.60 | 122.36 | 157.28 | - |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-320.66 | -167.93 | -1,560.91 | - |
|
Non-Operating Income
|
14.67 | -15.80 | 1.22 | - |
|
Interest Income
|
1.69 | - | - | - |
|
Interest Expense
|
22.17 | - | - | - |
|
Other Non-Op Income / Expense
|
1.46 | -0.25 | 2.76 | - |
|
Income Before Tax
|
-305.99 | -183.73 | -1,559.70 | - |
|
Income Tax Expense
|
-170.14 | -125.96 | -1,289.57 | 0.00 |
|
Non-Controlling Interest
|
-174.53 | -128.65 | -1,291.43 | - |
|
Net Income
|
-135.85 | -57.77 | -270.13 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-234.60 | -81.26 | -1,473.62 | 0.00 |
|
Earnings Per Share (Basic)
|
-0.94 | -0.61 | -6.50 | - |
|
Diluted EPS
|
-1.08 | -0.63 | -6.50 | - |
|
Weighted Average Shares
|
145.18 | 94.89 | 0.04 | - |
|
Diluted Weighted Avg Shares
|
147.00 | 294.59 | 0.04 | - |
|
Comprehensive Income
|
- | - | - | - |